PRVB
Provention Bio Inc

6,978
Loading...
Loading...
Provention Bio is a clinical-stage biopharmaceutical company dedicated to sourcing, developing, and commercializing novel therapeutics and cutting-edge solutions to intercept and prevent immune-mediated disease. Their predict and prevent model is focused on developing novel therapeutic approaches that intervene before the target disease begins, re-appears, or progresses. Provention Bio offers the potential to reduce the high morbidity, mortality, patient suffering, and escalating costs of chronic autoimmune and inflammatory diseases, such as type 1 diabetes (T1D), Crohnâ??s disease, ulcerative colitis, and emerging viral infections. They believe Proventionâ??s business model, coupled with its expertise in translational medicine, immunology, and the design and execution of rapid go/no-go clinical trials, will enable them to in-license and efficiently partner both early-stage development assets and more advanced clinical-stage opportunities.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Provention Bio Inc?
What is the 52-week high for Provention Bio Inc?
What is the 52-week low for Provention Bio Inc?
What is Provention Bio Inc stock price today?
What was Provention Bio Inc stock price yesterday?
What is the PE ratio of Provention Bio Inc?
What is the Price-to-Book ratio of Provention Bio Inc?
What is the 50-day moving average of Provention Bio Inc?

Latest PRVB News

View
No PRVB news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.